Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Expression of interleukin-22 in myasthenia gravis.

Zheng S, Dou C, Xin N, Wang J, Wang J, Li P, Fu L, Shen X, Cui G, Dong R, Lu J, Zhang Y.

Scand J Immunol. 2013 Jul;78(1):98-107. doi: 10.1111/sji.12057.

2.

[Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch].

Hu B, Tian X, Huang H, Jian A, Ouyang S, Yin W, Duan W, Yang H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Sep;35(9):958-63. doi: 10.3969/j.issn.1672-7347.2010.09.010. Chinese.

3.

Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis.

Li Y, Rauniyar VK, Yin WF, Hu B, Ouyang S, Xiao B, Yang H.

Neurol Sci. 2014 Jan;35(1):29-34. doi: 10.1007/s10072-013-1460-3. Epub 2013 May 26.

PMID:
23708911
5.

TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis.

Zhang Y, Shao Z, Zhang X, Jia X, Xia Y, Zhang Y, Xin N, Guo M, Chen J, Zheng S, Wang Y, Fu L, Dong R, Xiao C, Geng D, Liu Y.

J Neuroimmune Pharmacol. 2015 Dec;10(4):635-44. doi: 10.1007/s11481-015-9638-5. Epub 2015 Oct 24.

PMID:
26500105
6.
7.

Elevated serum level of interleukin-32α in the patients with myasthenia gravis.

Na SJ, So SH, Lee KO, Choi YC.

J Neurol. 2011 Oct;258(10):1865-70. doi: 10.1007/s00415-011-6036-7. Epub 2011 Apr 13.

PMID:
21487807
8.
9.

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.

Ostlie NS, Karachunski PI, Wang W, Monfardini C, Kronenberg M, Conti-Fine BM.

J Immunol. 2001 Apr 15;166(8):4853-62.

10.

Analysis of immunoglobulin secretion by lymph organs with myasthenia gravis.

Yoshikawa H, Satoh K, Yasukawa Y, Yamada M.

Acta Neurol Scand. 2001 Jan;103(1):53-8.

PMID:
11153889
11.

Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.

Aurangzeb S, Tariq M, Irshad M, Badshah M, Khan RS.

J Pak Med Assoc. 2009 May;59(5):289-92.

12.

Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.

Gunji K, Skolnick C, Bednarczuk T, Benes S, Ackrell BA, Cochran B, Kennerdell JS, Wall JR.

Clin Immunol Immunopathol. 1998 Jun;87(3):276-81.

PMID:
9646837
13.
14.

Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines.

Hohlfeld R, Kalies I, Kohleisen B, Heininger K, Conti-Tronconi B, Toyka KV.

Neurology. 1986 May;36(5):618-21.

PMID:
3486379
15.

[Antibodies in myasthenia gravis].

Eymard B.

Rev Neurol (Paris). 2009 Feb;165(2):137-43. doi: 10.1016/j.neurol.2008.11.020. Epub 2009 Jan 21. Review. French.

PMID:
19162288
17.

High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.

Yapici Z, Tüzün E, Altunayoğlu V, Erdoğan A, Eraksoy M.

Int J Neurosci. 2007 Nov;117(11):1505-12.

PMID:
17917921
18.
19.

Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.

Huang D, Shi FD, Giscombe R, Zhou Y, Ljunggren HG, Lefvert AK.

Eur J Immunol. 2001 Jan;31(1):225-32.

20.

Supplemental Content

Support Center